化合物详情
CAS7580-67-8
分子式HLi
分子量7.95 g/mol
危化品
Physical Description | Lithium hydride appears as a white or translucent crystalline mass or powder. The commercial product is light bluish-gray lumps due to the presence of minute amounts of colloidally dispersed lithium.
科学粮草官-词典编辑部,修订于:2026-07-06

Toxicity
ToxicityProbable Routes of Human Exposure
NIOSH (NOES Survey 1974) has statistically estimated that 11 workers are potentially exposed to lithium hydride in the US(1).
Symptoms
irritation eyes, skin; eye, skin burns; mouth, esophagus burns (if ingested); nausea; muscle twitches; mental confusion; blurred vision
Target Organs
Eyes, skin, respiratory system, central nervous system
Toxicity Data
LCLo (rat) = 10 mg/m3/4H
Adverse Effects
Toxic Pneumonitis - Inflammation of the lungs induced by inhalation of metal fumes or toxic gases and vapors.
Exposure Routes
inhalation, ingestion, skin and/or eye contact
Human Toxicity Excerpts
/SIGNS AND SYMPTOMS/ In atmospheres containing 0.5 mg/cu m, the skin becomes inflamed and lacrimation occurs.[American Conference of Governmental Industrial Hygienists, Inc. Documentation of the Threshold Limit Values and Biological Exposure Indices. 6th ed. Volumes I, II, III. Cincinnati, OH: ACGIH, 1991., p. 862]
Non-Human Toxicity Excerpts
/LABORATORY ANIMALS: Subchronic or Prechronic Exposure/ In a study on rats, guinea pigs and rabbits no histopathology attributable to lithium hydride was found in the lung, liver, kidney, trachea or lymph nodes 2-5 months after exposure to about 5 mg Li/cu m for 5 days (average exposure 4 hours/day).
Populations at Special Risk
In persons with impaired pulmonary function, especially those with obstructive airway diseases, the breathing of lithium hydride might cause exacerbation of symptoms due to its irritant properties. ... Persons with pre-existing skin disorders may be more susceptible to the effects of this agent. ... Persons with pre-existing eye conditions may be at increased risk from exposure.
Antidote and Emergency Treatment
Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious, has severe pulmonary edema, or is in severe respiratory distress. Positive-pressure ventilation techniques with a bag-valve-mask device may be beneficial. Consider drug therapy for pulmonary edema ... Monitor cardiac rhythm and treat arrhythmias if necessary ... Start IV administration of D5W /SRP: "To keep open", minimal flow rate/. Use 0.9% saline (NS) or lactated Ringer's (LR) if signs of hypovolemia are present. For hypotension with signs of hypovolemia, administer fluid cautiously. Consider vasopressors if patient is hypotensive with a normal fluid volume. Watch for signs of fluid overload ... Treat seizures with diazepam or lorazepam ... Use proparacaine hydroc...





